Tolerancia y perfil de efectos secundarios de bupropión

Roncero, Carlos; Fora, Facund; Galvez Ortiz, Verónica; Cardoner-Álvarez, Narcís; Crespo-Blanco, José M; Navarro-Odriozola, Víctor; García-Parés, Gemma; Pérez-Blanco, Josefina; Sánchez-Pérez, Manel.
Actas esp. psiquiatr ; 39(supl.2): 20-26, oct. 2011. graf
Artículo en Español | IBECS (España) | ID: ibc-97720

Documentos relacionados

  1. Selective deuteration of bupropion slows epimerization and reduces metabolism.
  2. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.
  3. Clinical Presentations of Bupropion Prescription Drug Misuse: A Systematic Review.
  4. Role of CYP2B6 pharmacogenomics in bupropion-mediated smoking cessation.
  5. Evaluation of a Potential Clinical Significant Drug-Drug Interaction between Digoxin and Bupropion in Cynomolgus Monkeys.
  6. Clinical effects of intravenous bupropion misuse reported to a regional poison center.
  7. Antidepressant-Induced Hyponatremia in Older Adults.
  8. Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.
  9. Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity.
  10. Delusional Infestation Due to Intravenous Abuse of Bupropion - Case Report.